Latest ESC 2019
HOPE 4: A Comprehensive Community-based Program Surpassing the Barriers in Improving BP Control and Associated Cardiovascular Disease Risk in 2 Middle Income Countries
Significant improvement in blood pressure control and related cardiovascular disease (CVD) risk…
ADRIFT Trial: Low-Dose Rivaroxaban is Superior to Dual Antiplatelet Therapy for Controlling Thrombin Generation after Left Atrial Appendage Closure in Atrial Fibrillation Patients
According to the results of Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban…
Dual Anti-thrombotic Therapy Safe For Patients with Atrial Fibrillation and Recent PCI:ENTRUST-AF PCI
Results from a phase-IIIb, open-label, multi-center, randomized clinical trial comparing the safety…
SYNTAXES Study: No Significant Difference In All-Cause Death At 10 Years Between PCI and CABG
A follow-up of a multicenter, randomized controlled trial, the results of which…